Supplementary Figure 1 from Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen–Positive Advanced/Metastatic Solid Tumors

2026 Open access

Read full text
Authors: Ignacio Melero, Josep M. Tabernero, Neeltje Steeghs, Debbie G. J. Robbrecht, Solange Peters, Naiyer A. Rizvi, Eileen Mary O'Reilly, Emiliano Calvo, Rikke Løvendahl Eefsen, Natasha B. Leighl, Andrès M.R. Cervantes, Navid Hafez
+13 more Christin Habigt, Emilia K. Andersson, David Dejardin, Eva D. Rossmann, Iris Martinez Quetglas, Galina Babitzki, José Manuel Duarte, Céline Adessi, Christophe Boetsch, Stefan Evers, Jehad Charo, Volker Teichgräber, Ulrik Lassen
DOI: 10.1158/1078-0432.31248706
Cited by: 0

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Monoclonal and Polyclonal Antibodies Research Immunotherapy and Immune Responses

Publication details

Publication date
4 February 2026